Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pan Pantziarka

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Frontiers in Pharmacology|July 3, 2018
"Hard" Drug Repurposing for Precision Oncology: The Missing Link?Pan Pantziarka, Gauthier Bouche, Nicolas André
Future Oncology (London, England)|December 12, 2019
Biased by design? Clinical trials and patient benefit in oncologyPan Pantziarka, Ciska Verbaanderd, Lydie Meheus
BMJ (Clinical Research Ed.)|June 28, 2018
New uses for old drugsPan Pantziarka, Munir Pirmohamed, Nasir Mirza
Frontiers in Pharmacology|December 6, 2021
A Database of Drug Repurposing Clinical Trials in OncologyPan Pantziarka, Liese Vandeborne, Gauthier Bouche
Cancers|January 11, 2025
Synergistic Potential of Antibiotics with Cancer TreatmentsGiuseppe Nardo, Pan Pantziarka, Matteo Conti
Frontiers in Pharmacology|April 12, 2019
A Computational Model of Tumor Growth and AnakoinosisPan Pantziarka, Lina Ghibelli, Albrecht Reichle
Trends in Cancer|August 8, 2017
Repurposing Drugs in Oncology: Next StepsCiska Verbaanderd, Lydie Meheus, Isabelle Huys, et al.
The Lancet. Oncology|December 3, 2020
Drug repurposing in oncologyGauthier Bouche, Craig Gedye, Lydie Meheus, et al.
Ecancermedicalscience|February 20, 2018
Does the oncology community have a rejection bias when it comes to repurposed drugs?Bishal Gyawali, Pan Pantziarka, Sergio Crispino, et al.
Ecancermedicalscience|November 12, 2015
The wisdom of crowds and the repurposing of artesunate as an anticancer drugYolanda Augustin, Sanjeev Krishna, Devinder Kumar, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Frontiers in Pharmacology|July 3, 2018
"Hard" Drug Repurposing for Precision Oncology: The Missing Link?Pan Pantziarka, Gauthier Bouche, Nicolas André
Future Oncology (London, England)|December 12, 2019
Biased by design? Clinical trials and patient benefit in oncologyPan Pantziarka, Ciska Verbaanderd, Lydie Meheus
BMJ (Clinical Research Ed.)|June 28, 2018
New uses for old drugsPan Pantziarka, Munir Pirmohamed, Nasir Mirza
Frontiers in Pharmacology|December 6, 2021
A Database of Drug Repurposing Clinical Trials in OncologyPan Pantziarka, Liese Vandeborne, Gauthier Bouche
Cancers|January 11, 2025
Synergistic Potential of Antibiotics with Cancer TreatmentsGiuseppe Nardo, Pan Pantziarka, Matteo Conti
Frontiers in Pharmacology|April 12, 2019
A Computational Model of Tumor Growth and AnakoinosisPan Pantziarka, Lina Ghibelli, Albrecht Reichle
Trends in Cancer|August 8, 2017
Repurposing Drugs in Oncology: Next StepsCiska Verbaanderd, Lydie Meheus, Isabelle Huys, et al.
The Lancet. Oncology|December 3, 2020
Drug repurposing in oncologyGauthier Bouche, Craig Gedye, Lydie Meheus, et al.
Ecancermedicalscience|February 20, 2018
Does the oncology community have a rejection bias when it comes to repurposed drugs?Bishal Gyawali, Pan Pantziarka, Sergio Crispino, et al.
Ecancermedicalscience|November 12, 2015
The wisdom of crowds and the repurposing of artesunate as an anticancer drugYolanda Augustin, Sanjeev Krishna, Devinder Kumar, et al.
Pageof 6